CVS GROUP PLC

Transaction in Own Shares • Dec 11, 2025

National Storage Mechanism | Additional information

RNS Number : 1001L

CVS Group plc

11 December 2025

11 December 2025

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

CVS announces that on 10 December 2025 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

Date of purchase:	10/12/2025
Aggregate number of Ordinary Shares purchased:	24,425
Lowest price paid per share (GBp):	1,218.00
Highest price paid per share (GBp):	1,236.00
Volume weighted average price paid per share (GBp):	1,228.06

CVS intends to cancel all of the purchased Ordinary Shares.

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have  70,891,292 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

The total number of voting rights in CVS is therefore  70,891,292 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

Since the commencement of the Share Buyback Programme, the Company has repurchased 849,491 Ordinary Shares in aggregate at a weighted average price of 1,215.79 pence per share.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

Individual transactions:

Number of Ordinary Shares purchased	Transaction price (GBp share)	Time of transaction (UK Time)	Transaction reference number	Trading Venue
632	1236	10/12/2025 09:03:02	1348989714704231	XLON
451	1236	10/12/2025 09:03:04	1348989714704235	XLON
139	1232	10/12/2025 09:32:26	1348989714706519	XLON
716	1232	10/12/2025 09:32:29	1348989714706527	XLON
702	1232	10/12/2025 10:04:10	1348989714708739	XLON
735	1230	10/12/2025 10:05:00	1348989714708840	XLON
737	1234	10/12/2025 10:41:39	1348989714711036	XLON
749	1234	10/12/2025 10:41:39	1348989714711040	XLON
71	1234	10/12/2025 10:41:44	1348989714711042	XLON
772	1232	10/12/2025 10:42:01	1348989714711060	XLON
34	1232	10/12/2025 10:44:01	1348989714711276	XLON
183	1232	10/12/2025 10:45:00	1348989714711369	XLON
60	1232	10/12/2025 10:45:00	1348989714711370	XLON
809	1234	10/12/2025 11:03:49	1348989714712577	XLON
848	1234	10/12/2025 11:23:22	1348989714713696	XLON
200	1234	10/12/2025 11:24:53	1348989714713773	XLON
869	1232	10/12/2025 11:27:19	1348989714713967	XLON
128	1232	10/12/2025 11:38:26	1348989714714838	XLON
292	1232	10/12/2025 11:38:26	1348989714714839	XLON
98	1232	10/12/2025 11:38:26	1348989714714840	XLON
108	1232	10/12/2025 11:41:33	1348989714715129	XLON
344	1232	10/12/2025 11:41:33	1348989714715130	XLON
229	1232	10/12/2025 11:43:56	1348989714715381	XLON
897	1232	10/12/2025 11:45:06	1348989714715526	XLON
900	1232	10/12/2025 11:55:24	1348989714716317	XLON
583	1232	10/12/2025 11:55:24	1348989714716322	XLON
462	1232	10/12/2025 11:55:57	1348989714716361	XLON
246	1232	10/12/2025 11:55:57	1348989714716362	XLON
415	1232	10/12/2025 11:56:02	1348989714716395	XLON
189	1232	10/12/2025 12:02:20	1348989714717078	XLON
150	1230	10/12/2025 12:02:20	1348989714717083	XLON
228	1230	10/12/2025 12:02:20	1348989714717084	XLON
171	1226	10/12/2025 12:03:01	1348989714717176	XLON
607	1226	10/12/2025 12:03:01	1348989714717177	XLON
775	1224	10/12/2025 12:12:16	1348989714717969	XLON
522	1224	10/12/2025 12:16:59	1348989714718444	XLON
751	1224	10/12/2025 12:18:43	1348989714718586	XLON
554	1224	10/12/2025 12:18:43	1348989714718591	XLON
423	1218	10/12/2025 12:20:08	1348989714718770	XLON
318	1218	10/12/2025 12:20:08	1348989714718771	XLON
182	1220	10/12/2025 12:27:25	1348989714719216	XLON
552	1220	10/12/2025 12:27:25	1348989714719217	XLON
6	1220	10/12/2025 12:38:53	1348989714719982	XLON
7	1220	10/12/2025 12:38:53	1348989714719983	XLON
3	1220	10/12/2025 12:38:53	1348989714719984	XLON
542	1220	10/12/2025 12:42:01	1348989714720209	XLON
182	1220	10/12/2025 12:42:01	1348989714720210	XLON
44	1222	10/12/2025 13:04:03	1348989714721785	XLON
10	1222	10/12/2025 13:04:03	1348989714721786	XLON
96	1222	10/12/2025 13:04:03	1348989714721787	XLON
48	1222	10/12/2025 13:04:03	1348989714721788	XLON
684	1224	10/12/2025 13:45:41	1348989714725418	XLON
509	1224	10/12/2025 13:45:41	1348989714725422	XLON
11	1224	10/12/2025 13:45:41	1348989714725423	XLON
200	1222	10/12/2025 14:06:54	1348989714727650	XLON
699	1220	10/12/2025 14:22:33	1348989714728978	XLON
140	1218	10/12/2025 14:22:35	1348989714728984	XLON
714	1218	10/12/2025 14:34:55	1348989714731296	XLON
204	1218	10/12/2025 14:36:01	1348989714731495	XLON
67	1218	10/12/2025 14:36:01	1348989714731496	XLON
258	1218	10/12/2025 14:39:12	1348989714732195	XLON
451	1224	10/12/2025 15:09:05	1348989714738505	XLON
291	1224	10/12/2025 15:09:05	1348989714738506	XLON
237	1222	10/12/2025 15:17:32	1348989714740270	XLON
96	1222	10/12/2025 15:21:54	1348989714741540	XLON
72	1222	10/12/2025 15:26:49	1348989714742410	XLON
23	1220	10/12/2025 15:35:04	1348989714743809	XLON

Contacts

CVS Group plc                                                                                                                                                 via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

Peel Hunt LLP (Nominated Adviser & Joint Broker)                                                                                  +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

Berenberg (Joint Broker)                                                                                                                             +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

Camarco (Financial PR)                                                                                                                             [email protected]

Ginny Pulbrook                                                                                                                                                +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

About CVS Group plc (www.cvsukltd.co.uk)

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSGPGBCPUPAPGU